Israeli National Cancer Registry

Tel Aviv, Israel

Israeli National Cancer Registry

Tel Aviv, Israel
SEARCH FILTERS
Time filter
Source Type

Shani H.,Susanne Levy Gertner Oncogenetics Unit | Keinan Boker L.,Israeli National Cancer Registry | Silverman B.G.,Israeli National Cancer Registry | Ottini L.,University of Rome La Sapienza | And 7 more authors.
Anticancer Research | Year: 2017

Background: Primary peritoneal serous carcinoma (PPSC) is a rare neoplasm. The paucity of reported cases among men may provide insight to the cell of origin of PPSC. Materials and Methods: A search for the ICD 0-3 code of PPSC (C48.2) in the following datasets: the Israeli National Cancer registry (INCR), the Surveillance, Epidemiology, and End Results (SEER) database in the USA, Israeli male BRCA carriers, male high-risk and BRCA carriers in a USA study, and the Italian Study on Male Breast Cancer (MBC) were performed. Results: In the INCR dataset, 220 entries for C48.2 code were noted, with only one male (male:female ratio=0.0045). In the SEER dataset for histology codes of papillary/serous/adenocarcinoma, 2,673 cases were recorded, with five males (male:female ratio=0.0018). None of the recorded US or Italian male BRCA carriers or MBC, or Israeli male BRCA carriers was diagnosed with PPSC. Conclusion: PPSC is a rare neoplasm, seemingly not associated with BRCA mutations in men, and fallopian tube epithelial cell implants may contribute to its development.

Loading Israeli National Cancer Registry collaborators
Loading Israeli National Cancer Registry collaborators